![Karl AIGNER | Head of Department | Professor Dr | Medias Klinikum, Burghausen | Department of Surgical Oncology Karl AIGNER | Head of Department | Professor Dr | Medias Klinikum, Burghausen | Department of Surgical Oncology](https://i1.rgstatic.net/ii/profile.image/272203660918807-1441909818516_Q512/Karl-Aigner.jpg)
Karl AIGNER | Head of Department | Professor Dr | Medias Klinikum, Burghausen | Department of Surgical Oncology
![Karl AIGNER | Head of Department | Professor Dr | Medias Klinikum, Burghausen | Department of Surgical Oncology Karl AIGNER | Head of Department | Professor Dr | Medias Klinikum, Burghausen | Department of Surgical Oncology](https://www.researchgate.net/profile/Karl-Aigner/publication/351139781/figure/fig4/AS:1017855512436736@1619687073152/Overall-survival-in-FIGO-stage-IIIC-pretreated-vs-non-pretreated-patients-OS-overall_Q320.jpg)
Karl AIGNER | Head of Department | Professor Dr | Medias Klinikum, Burghausen | Department of Surgical Oncology
![Carotid artery infusion via implantable catheters for squamous cell carcinoma of the tonsils | World Journal of Surgical Oncology | Full Text Carotid artery infusion via implantable catheters for squamous cell carcinoma of the tonsils | World Journal of Surgical Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12957-018-1404-8/MediaObjects/12957_2018_1404_Fig1_HTML.png)
Carotid artery infusion via implantable catheters for squamous cell carcinoma of the tonsils | World Journal of Surgical Oncology | Full Text
![Kornelia AIGNER | Group Leader | Diplom | Medias Klinikum, Burghausen | Department of Tumor Biology | profile on ResearchGate Kornelia AIGNER | Group Leader | Diplom | Medias Klinikum, Burghausen | Department of Tumor Biology | profile on ResearchGate](https://i1.rgstatic.net/ii/profile.image/870703725289472-1584603353322_Q512/Kornelia-Aigner.jpg)
Kornelia AIGNER | Group Leader | Diplom | Medias Klinikum, Burghausen | Department of Tumor Biology | profile on ResearchGate
Regional Chemotherapy Is a Valuable Second-Line Approach in Metastatic Esophageal Cancer after Failure to First-Line Palliative
![Medias Klinikum Burghausen: pioneering research in surgical oncology and regional chemotherapy – Kudos Medias Klinikum Burghausen: pioneering research in surgical oncology and regional chemotherapy – Kudos](https://static.growkudos.com/images/rg-outputs-images/88b4cc2e-82aa-4e42-9d23-c0513b77ca2a.png)
Medias Klinikum Burghausen: pioneering research in surgical oncology and regional chemotherapy – Kudos
![Medias Klinikum Burghausen: pioneering research in surgical oncology and regional chemotherapy – Kudos Medias Klinikum Burghausen: pioneering research in surgical oncology and regional chemotherapy – Kudos](https://static.growkudos.com/images/rg-outputs-images/a4dee7cd-74d4-412a-8ff7-332d5c1ab132.png)
Medias Klinikum Burghausen: pioneering research in surgical oncology and regional chemotherapy – Kudos
![Regional Chemotherapy Demystified | Interview with Prof. Dr. med. Karl R. Aigner | Part 1 | English | HD on Vimeo Regional Chemotherapy Demystified | Interview with Prof. Dr. med. Karl R. Aigner | Part 1 | English | HD on Vimeo](https://i.vimeocdn.com/video/605782445_1280x720.jpg)
Regional Chemotherapy Demystified | Interview with Prof. Dr. med. Karl R. Aigner | Part 1 | English | HD on Vimeo
![Current Oncology | Free Full-Text | Regional Chemotherapy Is a Valuable Second-Line Approach in Metastatic Esophageal Cancer after Failure to First-Line Palliative Treatment Current Oncology | Free Full-Text | Regional Chemotherapy Is a Valuable Second-Line Approach in Metastatic Esophageal Cancer after Failure to First-Line Palliative Treatment](https://www.mdpi.com/curroncol/curroncol-29-00386/article_deploy/html/images/curroncol-29-00386-g001.png)
Current Oncology | Free Full-Text | Regional Chemotherapy Is a Valuable Second-Line Approach in Metastatic Esophageal Cancer after Failure to First-Line Palliative Treatment
![Medias Klinikum Burghausen: pioneering research in surgical oncology and regional chemotherapy – Kudos Medias Klinikum Burghausen: pioneering research in surgical oncology and regional chemotherapy – Kudos](https://static.growkudos.com/images/rg-outputs-images/4d9badca-732a-4fdc-a983-3f366226b33c.png)
Medias Klinikum Burghausen: pioneering research in surgical oncology and regional chemotherapy – Kudos
Regional Chemotherapy Is a Valuable Second-Line Approach in Metastatic Esophageal Cancer after Failure to First-Line Palliative
![Medias Klinikum Burghausen: pioneering research in surgical oncology and regional chemotherapy – Kudos Medias Klinikum Burghausen: pioneering research in surgical oncology and regional chemotherapy – Kudos](https://static.growkudos.com/images/rg-project-logos/d003d340-532e-40d4-8796-a73af67b44ae..jpg)
Medias Klinikum Burghausen: pioneering research in surgical oncology and regional chemotherapy – Kudos
Combination of Loco-Regional Chemotherapy and Oncolytic Virotherapy to Treat a Metastatic Gastro-Esophageal Tumor
![Medias Klinikum Burghausen: pioneering research in surgical oncology and regional chemotherapy – Kudos Medias Klinikum Burghausen: pioneering research in surgical oncology and regional chemotherapy – Kudos](https://static.growkudos.com/images/rg-outputs-images/36717002-ecee-4435-9f29-c9708927383e.png)
Medias Klinikum Burghausen: pioneering research in surgical oncology and regional chemotherapy – Kudos
![Medias Klinikum Burghausen: pioneering research in surgical oncology and regional chemotherapy – Kudos Medias Klinikum Burghausen: pioneering research in surgical oncology and regional chemotherapy – Kudos](https://static.growkudos.com/images/rg-outputs-images/25894cf9-4ae9-46cc-ac5e-ab8d1f67ad2f.png)